Breaking News Instant updates and real-time market news.

GPRO

GoPro

$9.08

-0.48 (-5.02%)

, CREE

Cree

$29.28

-0.08 (-0.27%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Monday in GoPro (GPRO), Cree (CREE), ArcelorMittal (MT), Pioneer Natural (PXD), and Natus Medical (BABY).

GPRO

GoPro

$9.08

-0.48 (-5.02%)

CREE

Cree

$29.28

-0.08 (-0.27%)

MT

ArcelorMittal

$28.99

-0.36 (-1.23%)

PXD

Pioneer Natural

$143.69

-0.23 (-0.16%)

BABY

Natus Medical

$39.35

-0.75 (-1.87%)

  • 17

    Oct

  • 25

    Oct

  • 01

    Nov

  • 02

    Nov

GPRO GoPro
$9.08

-0.48 (-5.02%)

09/29/17
OPCO
09/29/17
NO CHANGE
OPCO
Perform
GoPro estimates raised on better software at Oppenheimer
Oppenheimer analyst Andrew Uerkwitz raised his estimates for GoPro citing confidence that the company can take share within the capture market. With QuickStories, image stabilization, faster device wifi, and smart scene detection, GoPro "is on the right track," Uerkwitz tells investors in a research note. The anlayst raised his 2017 earnings per share estimate for the company to 3c from (6c) from 2018 estimate to 50c from 0c. He keeps a Perform rating on GoPro.
09/08/17
SBSH
09/08/17
NO CHANGE
Target $10.5
SBSH
Neutral
GoPro price target raised to $10.50 from $9.50 at Citi
Citi analyst Stanley Kovler raised his price target for GoPro shares to $10.50 following the company's positive preannouncement. Sell-through in July was strong and good sales were experienced in August as well across all regions, Kovler tells investors in a research note. He maintains a Neutral rating on GoPro.
09/21/17
CLVD
09/21/17
NO CHANGE
CLVD
GoPro unit and earnings estimates raised through 2018 at Cleveland Research
Cleveland Research analyst Ben Bollin raised GoPro's unit and earnings assumptions through 2018. The analyst said feedback indicates 2017 units are trending to 4.7-4.8M units, versus 4.6-4.7M prior, and 2018 expectations suggest flat year-over-year performance, versus a low $4M range prior. The analyst adds Karma sales appear better on improved availability and the Wynit bankruptcy is not expected to be a significant headwind. Bollin rates GoPro shares a Neutral.
09/07/17
JPMS
09/07/17
NO CHANGE
Target $15
JPMS
Overweight
GoPro price target raised to $15 from $13 at JPMorgan
JPMorgan analyst Paul Coster adjusted his Q3 estimates for GoPro after the company reported that it now expects revenues and margins to come in at the high end of its previous guidance and he is also raising his multiple on the stock to account for its solid execution ahead of the launch of the Hero 6 camera. Given the raised multiple, Coster increased his price target on the stock to $15 from $13 and keeps an Overweight rating on GoPro shares.
CREE Cree
$29.28

-0.08 (-0.27%)

08/23/17
ROTH
08/23/17
NO CHANGE
Target $28
ROTH
Buy
Roth Capital remains a buyer of Cree on a potential Wolfspeed spinoff
Roth Capital analyst Craig Irwin notes that Cree reported essentially inline Q4 results, with Q1 guidance that primarily reflects increasing spend to support growth for Wolfspeed. The analyst reiterates a Buy rating on the shares for the significant value creation potential in a Wolfspeed spinoff, which would also allow increased focus on the core LED chips and components and lighting products businesses. Irwin also lowered his price target on the shares to $28 from $29.
10/12/17
GSCO
10/12/17
NO CHANGE
GSCO
Goldman Sachs Tactical Trades ahead of earnings
Goldman analysts led by John Marshall highlight some of the firm's most out-of-consensus opportunities ahead of the earnings season. The firm sees potential for upward earnings revisions to drive share upside in Caterpillar (CAT), ENGlobal (ENTG), McDonald's, (MCD) and Netflix (NFLX) and downwards earnings revisions to drive downside in Grainger (GWW), Cree (CREE), and Tesla (TSLA).
10/06/17
10/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Spirit Airlines (SAVE) downgraded to Hold from Buy at Deutsche Bank with analyst Michael Linenberg saying the company's revenue outlook "may face greater downside risk" than peers given the competitive intensity of its markets. 2. Albemarle (ALB) downgraded to Neutral from Conviction Buy at Goldman Sachs with analyst Robert Koort saying the company over the past two years has transformed from a value-oriented chemical stock into a "thematic growth engine" as investors shifted their focus to the potential of an electric vehicle revolution. 3. Cree (CREE) downgraded to Underweight from Neutral at JPMorgan with analyst Paul Coster citing valuation. 4. Valero (VLO) downgraded to Neutral from Overweight at JPMorgan with Phil Gresh citing valuation following the recent rally. 5. Walgreens Boots Alliance (WBA) downgraded to Equal Weight at Morgan Stanley with analyst Ricky Goldwasser saying he expects the company's guidance to come in below consensus estimates when it is provided later this month. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/17
JPMS
10/06/17
DOWNGRADE
Target $28
JPMS
Underweight
Cree downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Paul Coster downgraded Cree to Underweight citing valuation. The stock's 36% rally since the resignation of CEO Swoboda "seems rational but premature," Coster tells investors in a research note. He recommends Cree as a "tactical short" saying the "reality of near-term earnings could deflate the multiple" post this quarter's report. The analyst raised his price target for the shares to $28 from $23.
MT ArcelorMittal
$28.99

-0.36 (-1.23%)

07/12/17
DBAB
07/12/17
UPGRADE
Target $32
DBAB
Buy
Deutsche Bank sees potential double for ArcelorMittal, ups to Buy
Deutsche Bank analyst Bastian Synagowitz upgraded ArcelorMittal to Buy from Hold and raised his price target for the shares to $32 from $25. An attractive valuation and strong free cash flow yield provide a potential double from current share levels, Synagowitz tells investors in a research note. He believes the stock offers three "free options" relating to a potential rebound in iron ore prices, a stronger cycle in western markets and a potential recovery in Brazil.
07/12/17
DBAB
07/12/17
UPGRADE
DBAB
Buy
ArcelorMittal upgraded to Buy from Hold at Deutsche Bank
09/22/17
COWN
09/22/17
DOWNGRADE
Target $27
COWN
Market Perform
ArcelorMittal downgraded to Market Perform from Outperform at Cowen
Cowen analyst Novid Rassouli downgraded ArcelorMittal to Market Perform and cut its price target to $27 from $32 based on expectations iron ore and global steel prices are heading lower. The analyst said ArcelorMittal was helped by steel-side reform in China, which pushed Chinese steel prices to multi-year highs. Rassouli has a bearish near-term view on iron ore prices and is concerned with the company's heavy exposure to iron ore and international steel markets.
09/22/17
09/22/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Versartis (VSAR) was downgraded to Hold from Buy at SunTrust, to Underweight from Overweight at Barclays, to Neutral from Overweight at Piper Jaffray, and to Market Perform from Outperform at Cowen. 2. Tiffany (TIF) downgraded to Neutral from Buy at Goldman Sachs with analyst Lindsay Drucker Mann saying the company's high-end categories, including engagement, wedding and solitaire jewelry, decelerated in the last two quarters. 3. Airbus (EADSY) downgraded to Hold from Buy at Jefferies with analyst Sandy Morris saying the company's EBIT in fiscal 2018 and fiscal 2019 could track significantly below consensus expectations. 4. Alcoa (AA) downgraded to Hold from Buy at Berenberg with analyst Yuriy Vlasov saying Alcoa shares are up 43% over the past six months and recommends taking profits. 5. U.S. Steel (X) was downgraded to Underperform from Market Perform while ArcelorMittal (MT) was downgraded to Market Perform from Outperform at Cowen. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PXD Pioneer Natural
$143.69

-0.23 (-0.16%)

08/22/17
08/22/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on the today's top five analyst initiations with this list compiled by The Fly: 1. Redfin (RDFN) initiated with a Sector Perform at RBC Capital, Hold rating at Stifel, an Outperform at Oppenheimer and Neutral at Goldman Sachs. 2. Energen (EGN) initiated with an Outperform at Imperial Capital. 3. Pioneer Natural (PXD) initiated with an Outperform at Imperial Capital. 4. Revance (RVNC) initiated with an Outperform at JMP Securities. 5. Pacira (PCRX) initiated with a Buy at Needham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/29/17
JEFF
08/29/17
NO CHANGE
Target $25
JEFF
Buy
Jefferies cuts oil forecast, Exploration & Production price targets
Jefferies lowered its Brent estimate to $57 per barrel from $64 in 2018, to $60 from $67 in 2019, and to $65 from $70 in 2020. The market appears to be adequately supplied in the near term, but depleting proved developed reserves and shrinking spare capacity should support rising longer-term price assumption, analyst Michael Hsu tells investors in a research note. To reflect the reduced forecast, the analyst cut his price targets for names in the Exploration & Production space. Target cuts include Buy-rated Carrizo Oil & Gas (CRZO) to $25 from $32, Buy-rated Continental Resources (CLR) to $42 from $52, Buy-rated Newfield Exploration (NFX) to $40 from $46, Buy-rated Noble Energy (NBL) to $32 from $36, Buy-rated Oasis Petroleum (OAS) to $13 from $16, Buy-rated Pioneer Natural Resources (PXD) to $171 from $192 and Buy-rated Range Resources (RRC) to $36 from $37.
09/07/17
MUFG
09/07/17
NO CHANGE
Target $170
MUFG
Overweight
Pioneer Natural price target lowered to $170 from $230 at MUFG
MUFG analyst Michael McAllister lowered his price target for Pioneer Natural Resources to $170 and keeps an Overweight rating on the name. The analyst believes a 10.4 times expected 2018 EBITDA is a more appropriate valuation that "reflects the lack of urgency" in the investment community for Exploration and Production equities.
10/16/17
WOLF
10/16/17
DOWNGRADE
WOLF
Peer Perform
Pioneer Natural downgraded to Peer Perform from Outperform at Wolfe Research
BABY Natus Medical
$39.35

-0.75 (-1.87%)

04/27/17
ROTH
04/27/17
NO CHANGE
Target $41
ROTH
Buy
Natus Medical price target lowered to $41 from $47 at Roth Capital
Roth Capital analyst Chris Lewis lowered his price target for Natus Medical to $41 from $47 after the company reported mixed Q1 results with better than anticipated revenues driven by Otometrics offset by an EPS miss and 2017 EPS guidance downward revision on various unfavorable Newborn dynamics. The analyst reiterates a Buy rating on the shares.
02/02/17
02/02/17
DOWNGRADE

Market Perform
Natus Medical downgraded on sluggish base business growth at Raymond James
As previously reported, Raymond James downgraded Natus Medical to Market Perform from Outperform. Analyst Jayson Bedford said Natus' base business continues to struggle and is slightly below the low end of management's 2017 revenue guidance of approximately 3-4% revenue growth, which assumed a healthy increase in organic growth. Additionally, Bedford said operating margins are flattish in the base business and at approximately a 20x multiple, shares may have a difficult time moving higher.
02/02/17
RAJA
02/02/17
DOWNGRADE
RAJA
Market Perform
Natus Medical downgraded to Market Perform from Outperform at Raymond James
10/18/16
ROTH
10/18/16
NO CHANGE
Target $47
ROTH
Buy
Roth Capital remains a buyer of Natus Medical ahead of results
Roth Capital analyst Chris Lewis notes that Natus Medical is expected to release full quarterly earnings on Wednesday, but has already announced a Q3 revenue shortfall. While the analyst is disappointed with the miss, he believes the likely earning accretion from Otometrics acquisition should drive stock upside over the medium to long term. He reiterates a Buy rating and $47 price target on the shares.

TODAY'S FREE FLY STORIES

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 06

    Dec

WGL

WGL Holdings

$84.32

-0.14 (-0.17%)

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Earnings
WGL Holdings reports Q4 adjusted EPS (17c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

, LMOS

Lumos Networks

17:58
11/17/17
11/17
17:58
11/17/17
17:58
Hot Stocks
Tactile Systems to replace Lumos Networks in S&P 600 at open on 11/22 »

EQT Infrastructure…

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

, MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

17:56
11/17/17
11/17
17:56
11/17/17
17:56
Hot Stocks
Breaking Hot Stocks news story on Invesco Mortgage, MKS Instruments »

Invesco Mortgage to…

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

17:55
11/17/17
11/17
17:55
11/17/17
17:55
Hot Stocks
MKS Instruments to replace Brocade in S&P 400 at open on 11/22 »

S&P 500 constituent…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

UQM

UQM Technologies

$1.18

0.015 (1.29%)

17:24
11/17/17
11/17
17:24
11/17/17
17:24
Syndicate
Breaking Syndicate news story on UQM Technologies »

UQM Technologies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$238.02

-1.35 (-0.56%)

17:23
11/17/17
11/17
17:23
11/17/17
17:23
Periodicals
Goldman Sachs has $510M lawsuit dismissed, Reuters reports »

A $510M lawsuit that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICL

Vical

$1.94

-0.02 (-1.02%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Breaking Hot Stocks news story on Vical »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Ligand director sells 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CFO sells 6,559 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CEO sells 5,269 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBI

MBIA

$9.01

0.13 (1.46%)

17:15
11/17/17
11/17
17:15
11/17/17
17:15
Hot Stocks
Breaking Hot Stocks news story on MBIA »

Fine Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBCN

Rubicon

$8.07

0.1218 (1.53%)

17:03
11/17/17
11/17
17:03
11/17/17
17:03
Hot Stocks
Breaking Hot Stocks news story on Rubicon »

Bandera Partners reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANCB

Anchor Bancorp

$24.75

-0.1 (-0.40%)

17:02
11/17/17
11/17
17:02
11/17/17
17:02
Hot Stocks
Anchor Bancorp announces stock repurchase program, 10b5-1 trading plan »

Anchor Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIFI

Gulf Island Fabrication

$12.30

-0.1 (-0.81%)

16:58
11/17/17
11/17
16:58
11/17/17
16:58
Syndicate
Breaking Syndicate news story on Gulf Island Fabrication »

Gulf Island Fabrication…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$31.09

0.59 (1.93%)

16:51
11/17/17
11/17
16:51
11/17/17
16:51
Hot Stocks
Mid Penn Bancorp, Scottdale shareholders approve merger »

Mid Penn Bancorp and The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CALD

Callidus Software

$28.95

0.3 (1.05%)

16:49
11/17/17
11/17
16:49
11/17/17
16:49
Initiation
Callidus Software initiated at First Analysis »

Callidus Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIFI

Gulf Island Fabrication

$12.30

-0.1 (-0.81%)

16:46
11/17/17
11/17
16:46
11/17/17
16:46
Hot Stocks
Breaking Hot Stocks news story on Gulf Island Fabrication »

Piton Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

16:42
11/17/17
11/17
16:42
11/17/17
16:42
Hot Stocks
General Electric CEO acquires 60,000 common shares »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRE

Northstar Realty Europe

$14.20

0.05 (0.35%)

16:33
11/17/17
11/17
16:33
11/17/17
16:33
Syndicate
Breaking Syndicate news story on Northstar Realty Europe »

Northstar Realty Europe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

FHN

First Horizon

$18.40

0.1 (0.55%)

, CBF

Capital Bank

$39.95

0.25 (0.63%)

16:33
11/17/17
11/17
16:33
11/17/17
16:33
Hot Stocks
First Horizon, Capital Bank agree to sell two branches to Apex Bank »

First Horizon (FHN) and…

FHN

First Horizon

$18.40

0.1 (0.55%)

CBF

Capital Bank

$39.95

0.25 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$194.25

-0.75 (-0.38%)

16:32
11/17/17
11/17
16:32
11/17/17
16:32
Hot Stocks
Lennox executive sells 2,500 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

TBNK

Territorial Bancorp

$30.99

0.21 (0.68%)

16:31
11/17/17
11/17
16:31
11/17/17
16:31
Hot Stocks
Territorial Bancorp declares special cash dividend of 30c per share »

Payable on December 20.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRTN

Triton International

$40.07

-0.77 (-1.89%)

16:30
11/17/17
11/17
16:30
11/17/17
16:30
Hot Stocks
Triton International's Hanau sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
11/17/17
11/17
16:30
11/17/17
16:30
Options
Preliminary option volume of 21.1M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.